SUBSCRIBE
SUBSCRIBE
News   Business

Micrus Endovascular Corporation Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million

May 6, 2010 | 
1 min read

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq: MEND - News) today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance.

Earnings
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Stubborn Layoff Trend Continues Across Biopharma in 2024
December 23, 2024
 · 
207 min read
 · 
BioSpace Editorial Staff
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period
December 19, 2024
 · 
3 min read
 · 
Tristan Manalac
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
December 19, 2024
 · 
1 min read
 · 
Annalee Armstrong
Business
Analysis vs Beliefs, CEO Challenges, GLP-1 Investments
December 19, 2024
 · 
1 min read
 · 
Lori Ellis